NIBEC Co., Ltd. (KOSDAQ:138610)

South Korea flag South Korea · Delayed Price · Currency is KRW
25,650
+50 (0.20%)
At close: Jul 18, 2025, 3:30 PM KST
32.90%
Market Cap289.99B
Revenue (ttm)23.74B
Net Income (ttm)-11.07B
Shares Out11.31M
EPS (ttm)-1,016.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume51,527
Average Volume91,662
Open25,700
Previous Close25,600
Day's Range25,250 - 25,850
52-Week Range12,800 - 37,600
Beta1.14
RSI51.47
Earnings DateAug 14, 2025

About NIBEC

NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is headquartered in Jincheon-gun, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 96
Stock Exchange KOSDAQ
Ticker Symbol 138610
Full Company Profile

Financial Performance

In 2024, NIBEC's revenue was 24.55 billion, an increase of 56.33% compared to the previous year's 15.70 billion. Losses were -9.33 billion, 48.4% more than in 2023.

Financial Statements

News

There is no news available yet.